The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEnquest Regulatory News (ENQ)

Share Price Information for Enquest (ENQ)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 15.68
Bid: 15.50
Ask: 15.52
Change: 0.36 (2.35%)
Spread: 0.02 (0.129%)
Open: 14.88
High: 15.70
Low: 14.86
Prev. Close: 15.32
ENQ Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of AGM

6 Jun 2023 09:02

RNS Number : 7931B
EnQuest PLC
06 June 2023
 

EnQuest PLC ("EnQuest" or the "Company")

 

Voting results of the Annual General Meeting held on 5 June 2023

 

EnQuest announces that at the Company's Annual General Meeting held today, all resolutions set out in the Notice of Annual General Meeting and put to the meeting were passed by the requisite majority by way of a poll.

 

The results of the poll are set out below. The number of ordinary shares in issue is 1,885,924,339.

 

Resolution

For *

%

Against

%

Withheld **

1

 

Annual Report & Accounts 2022

893,535,854

99.95

469,813

0.05

4,634,354

The Directors are required to lay the Annual Report and Accounts before the shareholders each year at the AGM, including the reports of the Directors and Auditor.

2

 

Re-election of Amjad Bseisu

877,132,916

97.61

21,489,151

2.39

17,954

3

 

Election of Salman Malik

897,233,764

99.86

1,259,153

0.14

147,104

4

 

Election of Gareth Penny

889,007,532

98.94

9,487,484

1.06

145,005

5

 

Re-election Farina Khan

827,571,564

92.11

70,921,353

7.89

147,104

6

 

Re-election of Rani Koya

888,099,235

99.23

6,852,314

0.77

3,688,472

7

 

Re-election of Liv Monica Stubholt

895,883,440

99.71

2,600,576

0.29

156,005

The Directors have the power to appoint a Director during the year but any person so appointed must stand for election at the next AGM. A retiring Director is eligible to stand for re-election and, in accordance with best practice, each continuing Director stands for election or re-election at each AGM. Salman Malik and Gareth Penny stood for election having both been appointed during the year. Amjad Bseisu, Farina Khan, Rani Koya and Liv Monica Stubholt stood for re-election. Carl Hughes, John Winterman and Howard Paver did not stand for re-election and, accordingly, have stepped down from the Board following the conclusion of the 2023 AGM.

8

Re-Appointment of auditor

 

898,123,993

99.96

377,965

0.04

138,063

9

Authority to set auditor remuneration

898,007,077

99.95

487,603

0.05

145,341

The above resolutions serve to re-appoint Deloitte LLP as auditor of the Company to hold office from the conclusion of the AGM until the conclusion of the next AGM, at which accounts are laid before the Company, and to authorise the Audit Committee to set the auditor's remuneration.

10

Directors' Remuneration Report

765,121,393

85.73

127,331,465

14.27

6,187,163

This resolution approves the Directors' Remuneration Report, other than the part containing the Directors' Remuneration Policy for the financial year ended 31 December 2022. The current Directors' Remuneration Policy was approved at the 2021 AGM. The Report gives details of the payments and share awards made to Directors during the year ended 31 December 2022. This resolution constituted an advisory vote and no entitlement of a Director to remuneration is conditional upon it.

11

Political Donations

893,887,182

99.88

1,053,618

0.12

3,699,221

The Company does not make, nor intends to make, any political expenditure or donations. However, the Directors decided to seek shareholders' authority for political expenditure and donations incurred by the Company and its subsidiaries as the definition of political expenditure and donations under the Companies Act is very broad and could encompass activities in the normal course of business. The authority is capped at £60,000 for the year and expires at the next AGM or 30 June 2024, if earlier.

12

Authority to allot shares

894,029,107

99.49

4,602,507

0.51

8,407

Directors may only allot shares and grant rights to subscribe for, or convert any security into, shares if authorised to do so. This resolution allows Directors to allot ordinary shares up to one-third of the existing share capital or two- thirds of the existing share capital in connection with a rights issue. This authority will expire at the conclusion of the next AGM or 30 June 2024, if earlier.

13***

Disapplication of pre-emption rights

883,995,569

98.39

14,466,626

1.61

177,826

This resolution permits the Directors to allot equity securities or sell treasury shares for cash and otherwise than to existing shareholders pro rata to their holdings up to 5% of the Company's issued share capital as at 27 April 2023. This authority will expire at the next AGM or 30 June 2024, if earlier.

14***

Authority to purchase own shares

894,697,737

99.58

3,791,006

0.42

151,278

This resolution gives the Company authority to purchase its own shares in the market up to a limit of 10% of its issued ordinary share capital. This authority will expire at the next AGM or 30 June 2024, if earlier.

15***

Authority to call a general meeting not less than 14 days' notice

 

877,500,726

97.66

20,996,895

2.34

142,400

This resolution permits the Company to call a general meeting, other than an Annual General Meeting, on short notice, provided electronic voting is made available to all shareholders for that meeting.

 

* Includes discretionary votes

** A vote withheld is not a vote in law and is not counted for the purposes of the calculation of the proportion of votes 'For' or 'Against' a resolution

*** Indicates a Special Resolution

 

The full text of each resolution can be found in the Notice of Meeting which is available on the Company's website, www.enquest.com 

 

The Company will submit to the National Storage Mechanism copies of the Resolutions passed at the Annual General Meeting and these will shortly be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism

 

EnQuest remains focused on its strong balance sheet and its ongoing deleveraging strategy. As part of this financial policy, the Group will continue to assess funding opportunities to optimise the capital structure and manage its debt facilities, including engagement with sterling fixed income investors regarding a tap issue and exchange offer related to its retail bonds, which may follow subject to market conditions.

 

ENDS

 

For further information please contact:

 

EnQuest PLC Tel: +44 (0)20 7925 4900

 

Chris Sawyer (Company Secretary)

 

Notes to editors

 

ENQUEST

EnQuest is providing creative solutions through the energy transition. As an independent production and development company with operations in the UK North Sea and Malaysia, the Group's strategic vision is to be the operator of choice for maturing and underdeveloped hydrocarbon assets by focusing on operational excellence, differential capability, value enhancement and financial discipline.

EnQuest PLC trades on both the London Stock Exchange and the NASDAQ OMX Stockholm.

Please visit our website www.enquest.com for more information on our global operations.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGFIFEDRRIRIIV
Date   Source Headline
26th Apr 20243:00 pmRNSAnnual Financial Report
28th Mar 20247:01 amRNSResults for the year ended 31 December 2023
28th Mar 20247:00 amRNSDirectorate Change
28th Feb 202411:22 amRNSTotal Voting Rights
15th Feb 20247:00 amRNSFebruary Operations Update
30th Jan 202410:00 amRNSTermination of reporting issuer status in Canada
28th Dec 202310:01 amRNSTotal Voting Rights
22nd Dec 20237:00 amRNSSale of 15% of Bressay and EnQuest Producer FPSO
20th Dec 20234:46 pmRNSHolding(s) in Company
18th Dec 20234:00 pmRNSDirector Change
11th Dec 202311:34 amRNSDirector/PDMR Shareholding
7th Dec 20237:00 amRNSDirectorate Change - EnQuest New Energy Leadership
5th Dec 20233:30 pmRNSConfirmation of delisting date
5th Dec 20239:30 amRNSSubmission of delisting application
4th Dec 20235:34 pmRNSDirector/PDMR Shareholding
28th Nov 20237:00 amRNSEnQuest November Operations Update
24th Nov 20239:00 amRNSApplication for Block Listing
30th Oct 20234:50 pmRNSDirector/PDMR Shareholding
30th Oct 20232:00 pmRNSNasdaq Stockholm delisting update
28th Sep 20233:00 pmRNSHolding(s) in Company
26th Sep 202310:03 amRNSPDMR Notification
13th Sep 202311:04 amRNSDirectorate Change
5th Sep 20237:02 amRNSNasdaq Stockholm delisting application
5th Sep 20237:01 amRNSBoard appointment
5th Sep 20237:00 amRNSHalf-year Results
25th Aug 20232:09 pmRNSTerm loan facility agreement
19th Jul 20232:20 pmRNSDirector/PDMR Shareholding
22nd Jun 202312:06 pmRNSReport on Payments to Govts
6th Jun 20239:02 amRNSResult of AGM
5th Jun 20233:00 pmRNSHolding(s) in Company
24th May 20237:00 amRNSEnQuest May Operations Update
18th May 20232:30 pmRNSEnQuest awarded offer of carbon storage licences
9th May 20237:00 amRNSEnQuest Malaysia Update
28th Apr 20232:00 pmRNSNotice of AGM
25th Apr 20239:00 amRNSAnnual Financial Report
13th Apr 20234:54 pmRNSDirectorate Change
5th Apr 20237:00 amRNSResults for the year ended 31 December 2022
17th Mar 20237:00 amRNS2022 Preliminary Results - revised date
15th Mar 202311:00 amRNSHolding(s) in Company
17th Feb 20237:00 amRNSTrading Statement
20th Dec 20221:35 pmRNSDirector/PDMR Shareholding
6th Dec 20227:00 amRNSChairman succession
24th Nov 20227:00 amRNSOperations Update
26th Oct 20227:00 amRNSSuccessful refinancing of capital structure
13th Oct 20227:00 amRNSPricing of new bond issue
16th Sep 20223:30 pmRNSDirector/PDMR
16th Sep 20223:00 pmRNSDirector/PDMR Shareholding
6th Sep 20227:00 amRNSHalf-year Report
30th Aug 20229:00 amRNSHolding(s) in Company
2nd Aug 20227:00 amRNSOperations Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.